Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 24, 2016 - Issue 4
Submit an article Journal homepage
208
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Foveal Serous Retinal Detachment in Juvenile Idiopathic Arthritis-associated Uveitis

Feng LiangDepartment of Ophthalmology, University of Paris VI, Pitié-Salpêtrière Hospital, Paris, France,
, MD,
Celine TerradaDepartment of Ophthalmology, University of Paris VI, Pitié-Salpêtrière Hospital, Paris, France,
, MD, PhD,
Ghislaine Ducos de LahitteDepartment of Ophthalmology, University of Paris VI, Pitié-Salpêtrière Hospital, Paris, France,
, MD,
Pierre QuartierUnit of Immuno-Hematology and Pediatric Rheumatology, Necker-Enfants Malades Hospital, Paris, France,
, MD, PhD,
Phuc LehoangDepartment of Ophthalmology, University of Paris VI, Pitié-Salpêtrière Hospital, Paris, France,
, MD, PhD,
Jennifer E. ThorneDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, and ;Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA
, MD &
Bahram BodaghiDepartment of Ophthalmology, University of Paris VI, Pitié-Salpêtrière Hospital, Paris, France, Correspondence[email protected]
, MD, PhD show all
Pages 386-391 | Received 08 May 2014, Accepted 22 Jan 2015, Published online: 14 Jul 2015

References

  • Saurenmann RK, Levin AV, Feldman BM, et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum. 2007;56:647–657
  • Woreta F, Thorne JE, Jabs DA, et al. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;143:647–655
  • Foeldvari I, Nielsen S, Kümmerle-Deschner J, et al. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol. 2007;34:1146–1150
  • Thorne JE, Woreta F, Kedhar SR, et al. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143:840–846
  • Kump LI, Castañeda RA, Androudi SN, et al. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology. 2006;113:1874–1877
  • Ducos de lahitte G, Terrada C, Tran TH, et al. Maculopathy in uveitis of juvenile idiopathic arthritis: an optical coherence tomography study. Br J Ophthalmol. 2008;92:64–69
  • Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516. Review
  • Tappeiner C, Heinz C, Roesel M, et al. Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis. Acta Ophthalmol. 2011;89:e521–e527
  • Abedi G, Patal P, Doros G, et al. Transitioning from stratus OCT to cirrus OCT: a comparison and a proposed equation to convert central subfield macular thickness measurements in healthy subjects. Graefes Arch Clin Exp Ophthalmol. 2011;249:1353–1357
  • Davis JL, Dacanay LM, Holland GN, et al. Laser flare photometry and complications of chronic uveitis in children. Am J Ophthalmol. 2003;135:763–771
  • Gonzales CA, Ladas JG, Davis JL, et al. Relationships between laser flare photometry values and complications of uveitis. Arch Ophthalmol. 2001;119:1763–1769
  • Ossewaarde-van Norel J, Berg EM, Sijssens KM, Rothova A. Subfoveal serous retinal detachment in patients with uveitic macular edema. Arch Ophthalmol. 2011;129:158–162
  • Tran TH, de Smet MD, Bodaghi B, et al. Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. Br J Ophthalmol. 2008;92:922–927
  • Vitale AT, Graham E, de Boer JH. Juvenile idiopathic arthritis-associated uveitis: clinical features and complications, risk factors for severe course, and visual outcome. Ocul Immunol Inflamm. 2013;21:478–485

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.